| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Human Vascular endothelial growth factor receptor 2 |
|---|
| Description | 20-764aa; Extracellular Domain. MW: 110.6kD. Purity >90% as determined by SDS-PAGE. Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFA, VEGFC and VEGFD. Plays an essential role in the regulation of angiogenesis, vascular development, vascular permeability, and embryonic hatopoiesis. Promotes proliferation, survival, migration and differentiation of endothelial cells. Promotes reorganization of the actin cytoskeleton. Isoforms lacking a transmembrane domain, such as isoform 2 |
|---|
| Size | 0.01 mg (E-Coli), 0.05 mg (E-Coli), 0.1 mg (E-Coli), 0.2 mg (E-Coli), 0.5 mg (E-Coli) |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [Fetal liver kinase 1; FLK-1; Kinase insert domain receptor; KDR; Protein-tyrosine kinase receptor flk-1; CD309] |
|---|
| Gene, Accession, CAS # | KDR, Gene ID: 3791, Accession: NP_002244.1 |
|---|
| Catalog # | MBS967496 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human Vascular endothelial growth factor receptor 2 from MYBIOSOURCE INC. |
|---|
| Product Specific References | Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis.Jin P., Zhang J., Sumariwalla P.F., Ni I., Jorgensen B., Crawford D., Phillips S., Feldmann M., Shepard H.M., Paleolog E.M.Arthritis Res. Ther. 10:R73-R73(2008) Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth.Albuquerque R.J., Hayashi T., Cho W.G., Kleinman M.E., Dridi S., Takeda A., Baf |
|---|
| 产品资料 |
|
|